RIGL Competitors & Alternatives
Compare Rigel Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RIGL
Main Stock$35.61
Tradestie Score
64
Market Cap
$505.12M
P/E Ratio
1.7
Revenue Growth
0.1%
Analyst Upside
+52.2%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.81
|
$665.30M | - | 57 | Compare |
|
ANL
ANL
|
$10.60
|
$650.42M | - | 53 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.07
|
$626.91M | - | 60 | Compare |
|
SVRA
Savara Inc.
|
$5.78
|
$611.84M | - | 66 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.15
|
$552.46M | - | 57 | Compare |
|
VSTM
Verastem, Inc.
|
$4.21
|
$541.60M | - | 58 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.63
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.00
|
$529.35M | 6.4 | 64 | Compare |
More RIGL Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry